Prepare for Life.
Location: United States, California, San Diego
Employees: 201-500
Phone: +1 855-293-2639
Total raised: $125M
Founded date: 2010
Investors 1
| Date | Name | Website |
| - | Savitr Cap... | savitrcapi... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 07.11.2017 | - | $125M | - |
Mentions in press and media 6
| Date | Title | Description |
| 23.11.2021 | Progenity Gets $44 Million in Warrant Exercises Since August | By Chris Wack Progenity Inc. said it has received more than $44 million in warrant exercises since August. The biotechnology company said that as a result of previously issued warrants being exercised and other capital-raising transactions,... |
| 12.10.2021 | Progenity : announces it has successfully been assigned a patent for the treatment of a disease of the gastrointestinal tract | Patent number: 11134889 Abstract: This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with a SMAD7 inhibitor. Type: Grant Filed: December 14, 2017 Date of Patent: October 5, 2021 Assignee: P... |
| 24.08.2021 | Progenity Announces Closing of $40 Million Underwritten Public Offering | SAN DIEGO, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (“Progenity”) (Nasdaq: PROG), an innovative biotechnology company, today announced the closing of its previously announced underwritten public offering of 40,000,000 shares of its... |
| 20.08.2021 | Progenity Announces Pricing of $40 Million Public Offering of Common Stock and Warrants | SAN DIEGO, Aug. 19, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (“Progenity”) (Nasdaq: PROG), an innovative biotechnology company, today announced the pricing of its previously announced underwritten public offering of 40,000,000 shares of its... |
| 22.06.2020 | Biotech Progenity raises $100 million in initial public stock offering, shares fall | Progenity, a biotechnology company focused on precision medicine and testing for genetic diseases, became San Diego’s latest publicly traded company on Friday, raising $100 million in an initial public stock offering. The company sold 6.8 m... |
| 07.11.2017 | Progenity Picks Up $125M For Genetic Testing Efforts | San Diego-based Progenity, a provider of genetic testing technology aimed at women's health, reproductive medicine, and oncology, has raised $125M in a Series B funding, the company said on Tuesday. The funding round was led by Athyrium Cap... |